These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9046820)

  • 1. [Nasopharyngeal carcinoma: present and future].
    Ooka T
    Nihon Rinsho; 1997 Feb; 55(2):334-45. PubMed ID: 9046820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the DNase encoded by the BGLF5 gene of Epstein-Barr virus in nasopharyngeal carcinoma epithelial cells.
    Sbih-Lammali F; Berger F; Busson P; Ooka T
    Virology; 1996 Aug; 222(1):64-74. PubMed ID: 8806488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G; Agathanggelou A; Nicholls JM
    Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
    Brousset P; Butet V; Chittal S; Selves J; Delsol G
    Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and application of Epstein-Barr virus genome-wide genechip].
    Fang WY; Zheng WL; Ma WL; Liu Z; Li X; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1812-5. PubMed ID: 19778798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional expression of Epstein-Barr virus genes and proto-oncogenes in north African nasopharyngeal carcinoma.
    Sbih-Lammali F; Djennaoui D; Belaoui H; Bouguermouh A; Decaussin G; Ooka T
    J Med Virol; 1996 May; 49(1):7-14. PubMed ID: 8732865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal carcinoma: Epstein-Barr Virus significance.
    Kottaridis SD; Panotopoulou E; Diamantis I; Goula I; Danilidis J; Fountzilas G
    Anticancer Res; 1996; 16(2):785-9. PubMed ID: 8687129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
    Kumar S; Wairagkar NS; Mahanta J
    Indian J Cancer; 2001; 38(2-4):72-5. PubMed ID: 12593442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S; Yao K; Cao Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma.
    Hildesheim A; West S; DeVeyra E; De Guzman MF; Jurado A; Jones C; Imai J; Hinuma Y
    Cancer Res; 1992 Jun; 52(11):3048-51. PubMed ID: 1317256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China.
    Ji KM; Li CL; Meng G; Han AD; Wu XL
    Arch Virol; 2008; 153(10):1949-53. PubMed ID: 18807115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
    Liu JP; Cassar L; Pinto A; Li H
    Cell Res; 2006 Oct; 16(10):809-17. PubMed ID: 17016469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy].
    Busson P; Ooka T; Corbex M
    Med Sci (Paris); 2004 Apr; 20(4):453-7. PubMed ID: 15124119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
    Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
    Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
    Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
    N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.